HUTCHMED (China) (HMDCF) Shares Outstanding (Weighted Average) (2014 - 2025)
HUTCHMED (China) (HMDCF) reported Shares Outstanding (Weighted Average) of $110.4 million for Q4 2025, little changed year-over-year from $110.0 million in Q4 2024, and up 20821449.98% quarter-over-quarter from $530.0 in Q2 2025.
HUTCHMED (China) (HMDCF) Shares Outstanding (Weighted Average) (2014 - 2025) Analysis & Trends
HUTCHMED (China) (HMDCF) has 12 years of Shares Outstanding (Weighted Average) data on file, last reported at $110.4 million in Q4 2025.
- Shares Outstanding (Weighted Average) for Q4 2025 came in at $110.4 million, changed 0.3% year-over-year; the trailing twelve-month figure through Dec 2025 was $110.4 million (changed 0.3% YoY), and the FY2025 annual result was $110.4 million, changed 0.3% from the prior year.
- Shares Outstanding (Weighted Average) climbed to $110.4 million in Q4 2025 per HMDCF's latest filing, from $530.0 in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $110.4 million in Q4 2025 and troughed at $30.0 in Q2 2024.
- A 5-year average of $61.2 million and a median of $87.3 million in 2021 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2021 and 2025: Shares Outstanding (Weighted Average) sank 89.35% in 2021, then surged 1666.67% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $101.8 million in 2021, then climbed by 6.42% to $108.3 million in 2022, then increased by 0.41% to $108.7 million in 2023, then gained by 1.18% to $110.0 million in 2024, then gained by 0.3% to $110.4 million in 2025.
- Business Quant data shows HMDCF's Shares Outstanding (Weighted Average) at $110.4 million in Q4 2025, $530.0 in Q2 2025, and $110.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | HUTCHMED (China) | - | - | - | 110.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 110.35 Mn |
| Jun 30, 2025 | 530.00 |
| Dec 31, 2024 | 110.02 Mn |
| Jun 30, 2024 | 30.00 |
| Dec 31, 2023 | 108.74 Mn |
| Jun 30, 2023 | 200.00 |
| Dec 31, 2022 | 108.30 Mn |
| Dec 31, 2021 | 101.76 Mn |
| Jun 30, 2021 | 140.00 |
| Mar 31, 2021 | 72.81 Mn |
| Dec 31, 2020 | 72.77 Mn |
| Jun 30, 2020 | 70.00 |
| Mar 31, 2020 | 683.86 Mn |
| Sep 30, 2019 | 110.00 |
| Jun 30, 2019 | 70.00 |
| Mar 31, 2019 | 30.00 |
| Dec 31, 2018 | 664.26 Mn |
| Sep 30, 2018 | 90.00 |
| Jun 30, 2018 | 50.00 |
| Mar 31, 2018 | 20.00 |